Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's disease
Pharma
Lilly, Gilead-Yuhan, Leqembi—Fierce Pharma Asia
Lilly is making a series of investments in China. Gilead ended a MASH deal with Yuhan. A study suggests Leqembi's vial design is wasteful.
Angus Liu
Oct 18, 2024 8:20am
AbbVie's Vyalev wins FDA nod in Parkinson's after 2 rejections
Oct 17, 2024 10:34am
Aspen Neuroscience levels up in-house cell therapy production
Oct 2, 2024 8:15am
Acadia joins forces with Ryan Reynolds for Parkinson’s awareness
Aug 14, 2024 11:43am
Amneal's new Parkinson's drug passes muster with US regulators
Aug 8, 2024 3:26am
Merz to expand and hunt for more deals after closing Inbrija buy
Jul 11, 2024 4:08pm
